consumer-health

U.S. FTC requires divestitures in $13.53 billion Boehringer-Sanofi deal

German pharmaceutical company Boehringer Ingelheim agreed to divest five types of animal health products to settle charges that a proposed asset swap with Sanofi would harm competition, the U.S. Federal Trade Commission…

See original here:
U.S. FTC requires divestitures in $13.53 billion Boehringer-Sanofi deal